Tirzepatide for Weight Loss | Ideal Physician Weight Loss

Dual-action GLP-1 therapy

Physician-guided tirzepatide

FDA-approved tirzepatide activates GLP-1 and GIP receptors for enhanced appetite control — among the most effective physician-supervised weight loss medications available.

Dual hormone action
FDA-approved options
Once-weekly dosing
Licensed physicians

Check eligibility

Dual-action science

20%Average body weight loss in clinical trials

Overview

What is tirzepatide?

Tirzepatide is a dual-action medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors — two hormones involved in appetite regulation and metabolic health.

At Ideal Physician Weight Loss, licensed physicians evaluate whether tirzepatide is clinically appropriate for your weight management goals. Prescriptions may include FDA-approved branded medications such as Zepbound® or Mounjaro®, or compounded options when medically appropriate.

Like all GLP-1 therapies, tirzepatide works best as part of a comprehensive physician-guided program that includes nutrition support, lifestyle guidance, and ongoing medical monitoring.

Dual GLP-1 + GIP receptor agonist
Once-weekly injection
Zepbound® approved for chronic weight management
Mounjaro® approved for type 2 diabetes

Dual action

How tirzepatide's dual mechanism works

By targeting two key hormone pathways, tirzepatide offers enhanced appetite control and metabolic support compared to single-pathway GLP-1 therapies alone.

GLP-1 receptor activation

Reduces appetite signals in the brain and slows gastric emptying — helping you feel fuller, longer.

GIP receptor activation

GIP pathway engagement provides additional metabolic and appetite-regulating effects beyond GLP-1 alone.

Enhanced weight loss response

Clinical trials demonstrated greater average weight reduction with tirzepatide compared to semaglutide in head-to-head studies.

Gradual dose titration

Your physician increases your dose step-by-step to optimize tolerance and therapeutic effect.

Benefits

Why patients choose tirzepatide

Dual hormone action

Activates both GLP-1 and GIP receptors for enhanced appetite control and metabolic support.

Significant weight reduction

Clinical trials showed among the highest average body weight loss of any FDA-approved obesity medication studied.

Powerful appetite control

Patients often report substantial reductions in hunger and food preoccupation.

Once-weekly convenience

A single weekly injection fits easily into your routine with pharmacy-delivered supplies.

Physician oversight

Licensed doctors evaluate eligibility, prescribe, and monitor your progress throughout treatment.

Home pharmacy delivery

Prescriptions fulfilled by licensed U.S. pharmacies with discreet shipping in 3 to 5 business days.

Eligibility

Who is eligible

A licensed physician determines whether tirzepatide is appropriate based on your individual health profile, medical history, and treatment goals.

You may qualify if:

Adults with obesity or overweight who may benefit from dual-action GLP-1 therapy
Patients whose BMI and health history support tirzepatide treatment
Individuals without contraindications identified during medical evaluation
Patients in states served by our licensed telehealth physicians (48 states)
Those committed to ongoing physician supervision and lifestyle changes

May not be appropriate if:

Personal or family history of medullary thyroid carcinoma or MEN 2
Pregnancy or planning to become pregnant
History of serious allergic reaction to tirzepatide
Certain pancreatic, gallbladder, or kidney conditions — assessed by your physician

Tirzepatide is not appropriate for everyone. Complete our eligibility quiz for a personalized assessment by a licensed provider.

Check eligibility

Outcomes

Expected weight loss

Results vary by individual. Your physician establishes realistic goals based on your starting weight, health conditions, and adherence to your care plan.

1–2

Weeks

Appetite changes often begin early

20%

Body weight

Average reduction in SURMOUNT trials (Zepbound®)

3–6

Months

Meaningful progress with consistent treatment

Weeks 1–4

Dose escalation phase. Mild GI side effects are common and usually improve — contact your care team for support.

Months 1–3

Substantial appetite reduction and steady weight loss as therapeutic dose is established.

Months 3–6+

Continued results with physician-led dose optimization and comprehensive lifestyle support.

Timeline

Treatment timeline

1
Day 1 — Intake
Complete your health questionnaire. Our team reviews your profile and schedules your virtual visit.
2
Same day — Consultation
Licensed physician evaluates your eligibility for tirzepatide via secure telehealth.
3
If approved — Prescription
Your provider selects Zepbound®, Mounjaro®, or compounded tirzepatide based on your clinical needs.
4
3–5 days — Delivery
Medication shipped from a licensed pharmacy with injection supplies and instructions.
5
Ongoing — Optimization
Monthly check-ins, dose adjustments, and 24/7 support throughout your weight loss journey.

Formulations

Tirzepatide options

Zepbound®

Tirzepatide injection

FDA-approved for weight management

Dual-action medication targeting GLP-1 and GIP receptors, approved for chronic weight management in adults with obesity or overweight.

Mounjaro®

Tirzepatide injection

FDA-approved for type 2 diabetes

Contains tirzepatide and may be prescribed for weight management when a licensed provider determines it is clinically appropriate.

Compounded tirzepatide

Same active ingredient

Physician-prescribed alternative

Compounded tirzepatide may be available when clinically appropriate and prescribed by your licensed physician.

Safety

Safety information

Tirzepatide requires a prescription and must be used under ongoing physician supervision.

Your provider conducts a thorough medical evaluation before prescribing and monitors you throughout treatment.

Doses are increased gradually over weeks to improve tolerability and reduce gastrointestinal side effects.

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. Discuss your personal and family history with your physician.

Not for use during pregnancy. Tell your doctor about all medications, including insulin or sulfonylureas.

Individual results may vary. All medications carry potential risks. This page is for educational purposes and does not replace professional medical advice.

Side effects

Possible side effects

Common side effects

Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Indigestion
Injection site reactions

Serious side effects

Pancreatitis
Gallbladder problems
Kidney injury or worsening kidney disease
Severe allergic reactions
Low blood sugar (especially with insulin or sulfonylureas)

When to seek care: Reach out to your care team for persistent nausea or vomiting. Seek emergency care for severe abdominal pain, difficulty breathing, or signs of a serious allergic reaction.

FAQ

Tirzepatide questions

Semaglutide activates GLP-1 receptors only. Tirzepatide activates both GLP-1 and GIP receptors, which may produce greater average weight loss in clinical trials. Your physician helps determine which medication is best for you.

Both contain tirzepatide. Zepbound is FDA-approved for chronic weight management. Mounjaro is FDA-approved for type 2 diabetes. A licensed physician selects the appropriate formulation for your clinical needs.

In clinical trials, adults using tirzepatide for weight management lost an average of approximately 20% of body weight. Individual results vary based on adherence, starting weight, and medical factors.

Tirzepatide is typically administered as one subcutaneous injection per week. Your physician guides dose escalation and provides instructions with your pharmacy shipment.

Coverage varies by plan and indication. Our team can discuss pricing options — programs start at $299/month including consultation, medication, and support.

Explore tirzepatide treatment

Schedule a consultation with a licensed physician to find out if tirzepatide is right for your weight loss journey.

Get started

Compare semaglutide